Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Pain · Hyponatremia · CPIX

Cumberland Pharmaceuticals

CUMBERLAND PHARMACEUTICALS INC

Cumberland Pharmaceuticals clinical programs — 53 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
1600 W End Ave, #1300, Nashville, Tennessee 37203, US HQ
1999 Founded
128 Employees
Public company Type
CPIX · NYSE Ticker
Company details
Status
Public
HQ
1600 W End Ave, #1300, Nashville, Tennessee 37203, US
Founded
1999
Employees
128
Programs
53
Drugs
26
Patents
34
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

Cumberland Pharmaceuticals projects

53 ClinicalTrials.gov programs sponsored by Cumberland Pharmaceuticals.

Cumberland Pharmaceuticals has 53 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

53 programs

Clinical programs

Page 1 of 2

  1. Acetadote EF (Ethylenediaminetetraacetic Acid (EDTA) - Free)

    CUMBERLAND PHARMACEUTICALS INC

    Acetaminophen Overdose

    phase 3 small molecule terminated

    1 trial

  2. Caldolor

    CUMBERLAND PHARMACEUTICALS INC

    Pain

    phase 3 small molecule completed

    1 trial

  3. Caldolor

    CUMBERLAND PHARMACEUTICALS INC

    Burns

    phase 3 small molecule completed

    1 trial

  4. Caldolor

    CUMBERLAND PHARMACEUTICALS INC

    Fever

    phase 3 small molecule completed

    1 trial

  5. Conivaptan hydrochloride

    CUMBERLAND PHARMACEUTICALS INC

    Hyponatremia

    phase 3 small molecule terminated

    1 trial

  6. Ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Fever

    phase 3 small molecule completed

    2 trials

  7. Intravenous Ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Postoperative Pain

    phase 3 small molecule active

    1 trial

  8. Intravenous ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Tonsillectomy

    phase 3 small molecule completed

    1 trial

  9. Telavancin

    CUMBERLAND PHARMACEUTICALS INC

    Bacteremia

    phase 3 small molecule terminated

    1 trial

  10. Telavancin

    CUMBERLAND PHARMACEUTICALS INC

    Staphylococcal Skin Infection

    phase 3 small molecule completed

    2 trials

  11. Telavancin

    CUMBERLAND PHARMACEUTICALS INC

    Bacterial Pneumonia

    phase 3 small molecule completed

    2 trials

  12. YM087

    CUMBERLAND PHARMACEUTICALS INC

    Hyponatremia

    phase 3 small molecule completed

    1 trial

  13. YM087 oral

    CUMBERLAND PHARMACEUTICALS INC

    Hyponatremia

    phase 3 small molecule completed

    1 trial

  14. 90 grams of Crystalline Lactulose

    CUMBERLAND PHARMACEUTICALS INC

    Colonoscopy Preparation

    phase 2 small molecule completed

    1 trial

  15. Atorvastatin injection

    CUMBERLAND PHARMACEUTICALS INC

    Hypercholesterolemia

    phase 2 small molecule completed

    1 trial

  16. Crystalline Lactulose

    CUMBERLAND PHARMACEUTICALS INC

    Colonoscopy

    phase 2 small molecule completed

    1 trial

  17. Full dose preparation

    CUMBERLAND PHARMACEUTICALS INC

    Colonoscopy Preparation

    phase 2 small molecule completed

    1 trial

  18. Ifetroban

    CUMBERLAND PHARMACEUTICALS INC

    Duchenne Muscular Dystrophy Cardiomyopathy

    phase 2 small molecule completed

    1 trial

  19. Ifetroban

    CUMBERLAND PHARMACEUTICALS INC

    Portal Hypertension

    phase 2 small molecule completed

    1 trial

  20. Ifetroban Injection

    CUMBERLAND PHARMACEUTICALS INC

    Hepatorenal Syndrome

    phase 2 small molecule completed

    1 trial

  21. Ifetroban Oral Capsule

    CUMBERLAND PHARMACEUTICALS INC

    Asthma, Aspirin-Induced

    phase 2 small molecule completed

    1 trial

  22. Ifetroban Sodium

    CUMBERLAND PHARMACEUTICALS INC

    Malignant Solid Tumor

    phase 2 small molecule active

    1 trial

  23. Ifetroban Sodium

    CUMBERLAND PHARMACEUTICALS INC

    Cardiovascular Diseases

    phase 2 small molecule completed

    1 trial

  24. Ifetroban Sodium

    CUMBERLAND PHARMACEUTICALS INC

    Idiopathic Pulmonary Fibrosis

    phase 2 small molecule active

    1 trial

  25. Ifetroban, Oral Capsule

    CUMBERLAND PHARMACEUTICALS INC

    Aspirin Exacerbated Respiratory Disease (AERD)

    phase 2 small molecule completed

    1 trial

  26. N-Acetylcysteine (NAC)

    CUMBERLAND PHARMACEUTICALS INC

    Radiocontrast Nephropathy

    phase 2 small molecule completed

    1 trial

  27. Oral Ifetroban

    CUMBERLAND PHARMACEUTICALS INC

    Scleroderma, Diffuse

    phase 2 small molecule active

    1 trial

  28. Telavancin

    CUMBERLAND PHARMACEUTICALS INC

    Infections, Gram-Positive Bacterial

    phase 2 small molecule completed

    2 trials

  29. Telavancin

    CUMBERLAND PHARMACEUTICALS INC

    Gram-Positive Bacterial Infections

    phase 2 small molecule terminated

    2 trials

  30. conivaptan

    CUMBERLAND PHARMACEUTICALS INC

    Liver Cirrhosis

    phase 2 small molecule completed

    1 trial

  31. conivaptan

    CUMBERLAND PHARMACEUTICALS INC

    Chronic Heart Failure

    phase 2 small molecule completed

    1 trial

  32. ranibizumab

    CUMBERLAND PHARMACEUTICALS INC

    Retinal Vein Occlusion

    phase 2 small molecule completed

    1 trial

  33. Acetadote

    CUMBERLAND PHARMACEUTICALS INC

    Glioblastoma

    phase 1 small molecule active

    1 trial

  34. IVIb

    CUMBERLAND PHARMACEUTICALS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  35. Kristalose

    CUMBERLAND PHARMACEUTICALS INC

    Bowel Evacuant Prior to Colonoscopy

    phase 1 small molecule completed

    1 trial

  36. conivaptan hydrochloride

    CUMBERLAND PHARMACEUTICALS INC

    Kidney Diseases

    phase 1 small molecule completed

    1 trial

  37. conivaptan hydrochloride

    CUMBERLAND PHARMACEUTICALS INC

    Liver Disease

    phase 1 small molecule completed

    2 trials

  38. telavancin

    CUMBERLAND PHARMACEUTICALS INC

    Kidney Diseases

    phase 1 small molecule completed

    1 trial

  39. Conivaptan

    CUMBERLAND PHARMACEUTICALS INC

    Hyponatremia

    approved small molecule completed

    4 trials

  40. IV Ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Chronic Pelvic Pain

    approved small molecule active

    1 trial

  41. IV ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Arthroscopic Knee Surgery

    approved small molecule completed

    1 trial

  42. IV ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Pain

    approved small molecule completed

    1 trial

  43. Ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Ductus Arteriosus, Patent

    approved small molecule terminated

    1 trial

  44. Ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Pain

    approved small molecule completed

    1 trial

  45. Intravenous Ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Obesity

    approved small molecule completed

    1 trial

  46. Intravenous Ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Fever

    approved small molecule terminated

    1 trial

  47. Intravenous ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Pain

    approved small molecule completed

    3 trials

  48. Ofirmev

    CUMBERLAND PHARMACEUTICALS INC

    Pain

    approved small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Cumberland Pharmaceuticals have?

53 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.